相关实验视频

Updated: Jun 21, 2025

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

IMGT/mAb-KG:治疗单克隆抗体的知识图

Gaoussou Sanou^1,2, Taciana Manso¹, Konstantin Todorov²

¹The International ImMunoGeneTics Information System (IMGT), National Center for Scientific Research (CNRS), Institute of Human Genetics (IGH), University of Montpellier (UM), Montpellier, France.

Frontiers in immunology

|July 8, 2024

概括

一个新的知识图,IMGT/mAb-KG,通过将IMGT/mAb-DB与基因组和结构信息集成,提高了对治疗单克隆抗体 (mAb) 数据的访问. 这个资源有助于研究人员在mAb开发和理解.

科学领域:

免疫学免疫学免疫学
生物信息学是一种生物信息学.
药物发现药物发现药物发现

背景情况:

治疗性单克隆抗体 (mAbs) 对于治疗移植排斥,癌症和自身免疫性疾病至关重要.
像IMGT/mAb-DB这样的现有数据库提供了有价值的mAb信息,但在复杂的查询和数据集成方面存在局限性.
需要一个更相互连接和更全面的治疗mAb数据资源.

研究的目的:

开发IMGT/mAb-KG,一个知识图,将治疗单克隆抗体数据与IMGT结构和基因组数据库连接起来.
改善数据的可访问性,并为研究人员提供复杂的查询.
提高对mAb机制,构造和临床应用的理解.

主要方法:

创建IMGT/mAb-KG使用语义网络标准和方法.
将IMGT/mAb-DB的数据集成到知识图中.
通过重复使用来自生物医学资源的术语和链接到外部数据库来确保互操作性.

主要成果:

截至2024年2月,IMGT/mAb-KG包含139,629个三胞胎,可以访问1,489 mAbs,~500个目标和>500个临床适应症.
知识图提供了对 mAb 行动机制,构建,产品和相关研究的见解.
IMGT/mAb-KG与Thera-SAbDab,PharmGKB,PubMed和HGNC等外部资源联系在一起.

结论:

IMGT/mAb-KG是治疗单克隆抗体开发的重要,相互连接的资源.
知识图通过一个用户友好的界面来促进mAb数据的探索和分析.
这种综合方法增强了治疗性抗体领域的研究能力.

关键词:

免疫遗传学免疫遗传学免疫信息学是一种免疫信息学.知识图表知识图表在本体论上,本体论是存在的.语义网络是一个语义网络.治疗性单克隆抗体治疗性单克隆抗体视觉化的可视化

更多相关视频

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

Laboratory Scale Production and Purification of a Therapeutic Antibody

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

相关概念视频

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...